Test Code ALBR Albumin, Random, Urine
Ordering Guidance
Specimen Required
Patient Preparation: Heavy exercise should be avoided prior to collection.
Supplies: Sarstedt 5 mL Aliquot Tube (T914)
Container/Tube: Plastic tube
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. No preservative.
Useful For
Assessing the potential for early onset of nephropathy in diabetic patients using random urine specimens
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
RALB1 | Albumin, Random, U | No | Yes |
CRE2 | Creatinine | No | Yes |
A_CR | Albumin/Creatinine Ratio | No | Yes |
Method Name
RALB1: Immunoturbidity
CRE2: Enzymatic Colorimetric Assay
Reporting Name
Albumin, Random, USpecimen Type
UrineSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 7 days | |
Ambient | 7 days | ||
Frozen | 7 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability. |
Reference Values
Males: <17 mg/g creatinine
Females: <25 mg/g creatinine
Day(s) Performed
Monday through Sunday
Report Available
1 to 3 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82043
82570
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ALBR | Albumin, Random, U | 9318-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
RALB1 | Albumin, Random, U | 89999-7 |
CRE2 | Creatinine | 2161-8 |
A_CR | Albumin/Creatinine Ratio | 9318-7 |
NY State Approved
YesForms
If not ordering electronically, complete, print, and send a Renal Diagnostics Test Request (T830) with the specimen.